{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:18:56Z","timestamp":1764260336199,"version":"3.40.5"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CVP"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Classical risk factors for atherosclerosis also play a role in the pathogenesis of venous\nthromboembolism (VTE). Low-density lipoprotein cholesterol has prothrombotic and endothelium-\ndeteriorating effects which are not limited to the arterial system. The association between hypercholesterolemia\nand VTE has been established, but the benefits of statins in the prevention of\nVTE assessed by observation studies seemed equivocal. The large, randomized trial Justification\nfor the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) recorded\nthe occurrence of VTE as a protocol-specified endpoint and reported a reduced incidence\nof VTE among subjects taking 20 mg of rosuvastatin daily vs placebo (hazard ratio 0.57; 95% confidence\ninterval 0.37-0.86; p=0.007). Similar results were confirmed by meta-analyses of observation\nstudies and randomized trials. Recently, a Mendelian randomization study that took the presence\nof gene variants coding for less efficient hydroxymethyl-glutaryl coenzyme A reductase activity\nas a proxy for statin treatment, confirmed a small, but significant negative association between\nthe score of selected genetic polymorphisms and the incidence of VTE. However, since the\nprotective effects of statins are limited, they should not be substituted for guideline-recommended\nVTE prophylaxis or anticoagulation treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115701611308323240229050237","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T11:35:06Z","timestamp":1709638506000},"page":"297-300","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Statins and Venous Thromboembolic Disease \u2013 Where are we Now?"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9913-1419","authenticated-orcid":true,"given":"Pavel","family":"Poredo\u0161","sequence":"first","affiliation":[{"name":"Department of Vascular Diseases, University Medical Centre Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-3694","authenticated-orcid":true,"given":"Debabrata","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,\nTexas Tech University Health Sciences Center at El Paso, Texas 79905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7538-1595","authenticated-orcid":true,"given":"Ale\u0161","family":"Blinc","sequence":"additional","affiliation":[{"name":"Department of Vascular Diseases, University Medical Centre Ljubljana, Slovenia"},{"name":"Department of Internal Medicine, Faculty\nof Medicine, University of Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2141.2008.07323.x","volume":"143","author":"Bagot C.N.","year":"2008","unstructured":"Bagot C.N.; Arya R.; Virchow and his triad: A question of attribution. Br J Haematol  2008,143(2),180-190","journal-title":"Br J Haematol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"01","DOI":"10.1160\/TH09-05-0292","volume":"102","author":"Goldhaber S.Z.","year":"2009","unstructured":"Goldhaber S.Z.; Venous thromboembolism prophylaxis: Quality, location (hospital vs. home), and duration. Thromb Haemost  2009,102(7),01-02","journal-title":"Thromb Haemost"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/1358863X14568706","volume":"20","author":"Piazza G.","year":"2015","unstructured":"Piazza G.; Beyond virchow\u2019s triad: Does cardiovascular inflammation explain the recurrent nature of venous thromboembolism? Vasc Med  2015,20(2),102-104","journal-title":"Vasc Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJMoa022157","volume":"348","author":"Prandoni P.","year":"2003","unstructured":"Prandoni P.; Bilora F.; Marchiori A.; Bernardi E.; Petrobelli F.; Lensing A.W.A.; Prins M.H.; Girolami A.; An association between atherosclerosis and venous thrombosis. N Engl J Med  2003,348(15),1435-1441","journal-title":"N Engl J Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1055\/s-0031-1297368","volume":"37","author":"Poredos P.","year":"2011","unstructured":"Poredos P.; Jezovnik M.K.; Dyslipidemia, statins, and venous thromboembolism. Semin Thromb Hemost  2011,37(8),897-902","journal-title":"Semin Thromb Hemost"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","volume":"117","author":"Ageno W.","year":"2008","unstructured":"Ageno W.; Becattini C.; Brighton T.; Selby R.; Kamphuisen P.W.; Cardiovascular risk factors and venous thromboembolism: A meta-analysis. Circulation  2008,117(1),93-102","journal-title":"Circulation"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.116.025024","volume":"135","author":"Anand S.S.","year":"2017","unstructured":"Anand S.S.; Smoking. Circulation  2017,135(1),17-20","journal-title":"Circulation"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0049-3848(97)00192-8","volume":"88","author":"Kawasaki T.","year":"1997","unstructured":"Kawasaki T.; Kambayashi J.; Ariyoshi H.; Sakon M.; Suehisa E.; Monden M.; Hypercholesterolemia as a risk factor for deep-vein thrombosis. Thromb Res  1997,88(1),67-73","journal-title":"Thromb Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/1570161033476772","volume":"1","author":"Ferroni P.","year":"2003","unstructured":"Ferroni P.; Basili S.; Davi G.; Platelet activation, inflammatory mediators and hypercholesterolemia. Curr Vasc Pharmacol  2003,1(2),157-169","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1182\/blood-2016-01-631259","volume":"127","author":"Wang N.","year":"2016","unstructured":"Wang N.; Tall A.R.; Cholesterol in platelet biogenesis and activation. Blood  2016,127(16),1949-1953","journal-title":"Blood"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/cells12091293","volume":"12","author":"Higashi Y.","year":"2023","unstructured":"Higashi Y.; Endothelial function in dyslipidemia: Roles of LDL-cholesterol, HDL-cholesterol and triglycerides. Cells  2023,12(9),1293","journal-title":"Cells"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1177\/0003319717732238","volume":"69","author":"Poredos P.","year":"2018","unstructured":"Poredos P.; Jezovnik M.K.; Endothelial dysfunction and venous thrombosis. Angiology  2018,69(7),564-567","journal-title":"Angiology"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.amjmed.2007.01.029","volume":"120","author":"Sofi F.","year":"2007","unstructured":"Sofi F.; Marcucci R.; Abbate R.; Gensini G.F.; Prisco D.; Lipoprotein (a) and venous thromboembolism in adults: A meta-analysis. Am J Med  2007,120(8),728-733","journal-title":"Am J Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/5051434","volume":"2022","author":"Vaseghi G.","year":"2022","unstructured":"Vaseghi G.; Ghahdarijani H.K.; Taheri M.; Ghasempoor G.; Hajian S.; Javanmard H.S.; Aliyari R.; Shafiee Z.; Shekarchizadeh M.; Pourmoghadas A.; Sarrafzadegan N.; Hematological inflammatory markers in patients with clinically confirmed familial hypercholesterolemia. BioMed Res Int  2022,2022,1-6","journal-title":"BioMed Res Int"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"Mach F.","year":"2020","unstructured":"Mach F.; Baigent C.; Catapano A.L.; Koskinas K.C.; Casula M.; Badimon L.; Chapman M.J.; De Backer G.G.; Delgado V.; Ference B.A.; Graham I.M.; Halliday A.; Landmesser U.; Mihaylova B.; Pedersen T.R.; Riccardi G.; Richter D.J.; Sabatine M.S.; Taskinen M.R.; Tokgozoglu L.; Wiklund O.; Mueller C.; Drexel H.; Aboyans V.; Corsini A.; Doehner W.; Farnier M.; Gigante B.; Kayikcioglu M.; Krstacic G.; Lambrinou E.; Lewis B.S.; Masip J.; Moulin P.; Petersen S.; Petronio A.S.; Piepoli M.F.; Pint\u00f3 X.; R\u00e4ber L.; Ray K.K.; Reiner \u017d.; Riesen W.F.; Roffi M.; Schmid J-P.; Shlyakhto E.; Simpson I.A.; Stroes E.; Sudano I.; Tselepis A.D.; Viigimaa M.; Vindis C.; Vonbank A.; Vrablik M.; Vrsalovic M.; Zamorano J.L.; Collet J-P.; Koskinas K.C.; Casula M.; Badimon L.; Chapman J.M.; De Backer G.G.; Delgado V.; Ference B.A.; Graham I.M.; Halliday A.; Landmesser U.; Mihaylova B.; Pedersen T.R.; Riccardi G.; Richter D.J.; Sabatine M.S.; Taskinen M-R.; Tokgozoglu L.; Wiklund O.; Windecker S.; Aboyans V.; Baigent C.; Collet J-P.; Dean V.; Delgado V.; Fitzsimons D.; Gale C.P.; Grobbee D.; Halvorsen S.; Hindricks G.; Iung B.; J\u00fcni P.; Katus H.A.; Landmesser U.; Leclercq C.; Lettino M.; Lewis B.S.; Merkely B.; Mueller C.; Petersen S.; Petronio A.S.; Richter D.J.; Roffi M.; Shlyakhto E.; Simpson I.A.; Sousa-Uva M.; Touyz R.M.; Nibouche D.; Zelveian P.H.; Siostrzonek P.; Najafov R.; van de Borne P.; Pojskic B.; Postadzhiyan A.; Kypris L.; \u0160pinar J.; Larsen M.L.; Eldin H.S.; Viigimaa M.; Strandberg T.E.; Ferri\u00e8res J.; Agladze R.; Laufs U.; Rallidis L.; Bajnok L.; Gudj\u00f3nsson T.; Maher V.; Henkin Y.; Gulizia M.M.; Mussagaliyeva A.; Bajraktari G.; Kerimkulova A.; Latkovskis G.; Hamoui O.; Slapikas R.; Visser L.; Dingli P.; Ivanov V.; Boskovic A.; Nazzi M.; Visseren F.; Mitevska I.; Retterst\u00f8l K.; Jankowski P.; Fontes-Carvalho R.; Gaita D.; Ezhov M.; Foscoli M.; Giga V.; Pella D.; Fras Z.; de Isla L.P.; Hagstr\u00f6m E.; Lehmann R.; Abid L.; Ozdogan O.; Mitchenko O.; Patel R.S.; 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J  2020,41(1),111-188","journal-title":"Eur Heart J"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1161\/01.CIR.0000019406.74017.B2","volume":"105","author":"Herrington D.M.","year":"2002","unstructured":"Herrington D.M.; Vittinghoff E.; Lin F.; Fong J.; Harris F.; Hunninghake D.; Bittner V.; Schrott H.G.; Blumenthal R.S.; Levy R.; Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen\/Progestin Replacement Study (HERS). Circulation  2002,105(25),2962-2967","journal-title":"Circulation"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e2348213","DOI":"10.1001\/jamanetworkopen.2023.48213","volume":"6","author":"Davis J.W.","year":"2023","unstructured":"Davis J.W.; Weller S.C.; Porterfield L.; Chen L.; Wilkinson G.S.; Statin use and the risk of venous thromboembolism in women taking hormone therapy. JAMA Netw Open  2023,6(12),e2348213","journal-title":"JAMA Netw Open"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2018.02.035","volume":"271","author":"Zaccardi F.","year":"2018","unstructured":"Zaccardi F.; Kunutsor S.K.; Seidu S.; Davies M.J.; Khunti K.; Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis  2018,271,223-231","journal-title":"Atherosclerosis"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","volume":"360","author":"Glynn R.J.","year":"2009","unstructured":"Glynn R.J.; Danielson E.; Fonseca F.A.H.; Genest J.; Gotto A.M.; Kastelein J.J.P.; Koenig W.; Libby P.; Lorenzatti A.J.; MacFadyen J.G.; Nordestgaard B.G.; Shepherd J.; Willerson J.T.; Ridker P.M.; A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med  2009,360(18),1851-1861","journal-title":"N Engl J Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1742-1241.2010.02439.x","volume":"64","author":"Agarwal V.","year":"2010","unstructured":"Agarwal V.; Phung O.J.; Tongbram V.; Bhardwaj A.; Coleman C.I.; Statin use and the prevention of venous thromboembolism: A meta-analysis. Int J Clin Pract  2010,64(10),1375-1383","journal-title":"Int J Clin Pract"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"105413","DOI":"10.1016\/j.phrs.2020.105413","volume":"165","author":"Li R.","year":"2021","unstructured":"Li R.; Yuan M.; Yu S.; Fu W.; Yu W.; Ling S.; Sun J.; Chen Y.; Effect of statins on the risk of recurrent venous thromboembolism: A systematic review and meta-analysis. Pharmacol Res  2021,165,105413","journal-title":"Pharmacol Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11239-012-0687-9","volume":"33","author":"Rodriguez A.L.","year":"2012","unstructured":"Rodriguez A.L.; Wojcik B.M.; Wrobleski S.K.; Myers D.D.; Wakefield T.W.; Diaz J.A.; Statins, inflammation and deep vein thrombosis: A systematic review. J Thromb Thrombolysis  2012,33(4),371-382","journal-title":"J Thromb Thrombolysis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2125.2008.03308.x","volume":"67","author":"Smeeth L.","year":"2009","unstructured":"Smeeth L.; Douglas I.; Hall A.J.; Hubbard R.; Evans S.; Effect of statins on a wide range of health outcomes: A cohort study validated by comparison with randomized trials. Br J Clin Pharmacol  2009,67(1),99-109","journal-title":"Br J Clin Pharmacol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1538-7836.2004.00696.x","volume":"2","author":"Doggen C.J.M.","year":"2004","unstructured":"Doggen C.J.M.; Lemaitre R.N.; Smith N.L.; Heckbert S.R.; Psaty B.M.; HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost  2004,2(5),700-701","journal-title":"J Thromb Haemost"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.0306-5251.2001.01523.x","volume":"53","author":"Yang C.C.","year":"2002","unstructured":"Yang C.C.; Jick S.S.; Jick H.; Statins and the risk of idiopathic venous thromboembolism. Br J Clin Pharmacol  2002,53(1),101-105","journal-title":"Br J Clin Pharmacol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1477-9560-12-26","volume":"12","author":"Wells P.S.","year":"2014","unstructured":"Wells P.S.; Gebel M.; Prins M.H.; Davidson B.L.; Lensing A.W.A.; Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy. Thromb J  2014,12(1),26","journal-title":"Thromb J"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.thromres.2012.08.296","volume":"130","author":"Delluc A.","year":"2012","unstructured":"Delluc A.; Tromeur C.; Le Moigne E.; Nowak E.; Mottier D.; Le Gal G.; Lacut K.; Lipid lowering drugs and the risk of recurrent venous thromboembolism. Thromb Res  2012,130(6),859-863","journal-title":"Thromb Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/rth2.12003","volume":"1","author":"Br\u00e6kkan S.K.","year":"2017","unstructured":"Br\u00e6kkan S.K.; Deelder C.C.; Siegerink B.; van Vlieg H.A.; le Cessie S.; Rosendaal F.R.; Cannegieter S.C.; Lijfering W.M.; Statin use and risk of recurrent venous thrombosis: Results from the MEGA follow\u2010up study. Res Pract Thromb Haemost  2017,1(1),112-119","journal-title":"Res Pract Thromb Haemost"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejim.2019.07.028","volume":"68","author":"Siniscalchi C.","year":"2019","unstructured":"Siniscalchi C.; Quintavalla R.; Rocci A.; Mestre R.A.; Santos J.; Suri\u00f1ach J.M.; Palomares J.L.; Bikdeli B.; Moustafa F.; Monreal M.; Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry. Eur J Intern Med  2019,68,30-35","journal-title":"Eur J Intern Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1055\/s-0040-1708877","volume":"120","author":"Albertsen I.E.","year":"2020","unstructured":"Albertsen I.E.; S\u00f8gaard M.; Goldhaber S.Z.; Piazza G.; Skj\u00f8th F.; Overvad T.F.; Larsen T.B.; Nielsen P.B.; Development of sex-stratified prediction models for recurrent venous thromboembolism: A danish nationwide cohort study. Thromb Haemost  2020,120(5),805-814","journal-title":"Thromb Haemost"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1161\/CIRCULATIONAHA.120.046397","volume":"141","author":"Marston N.A.","year":"2020","unstructured":"Marston N.A.; Gurmu Y.; Melloni G.E.M.; Bonaca M.; Gencer B.; Sever P.S.; Pedersen T.R.; Keech A.C.; Roselli C.; Lubitz S.A.; Ellinor P.T.; O\u2019Donoghue M.L.; Giugliano R.P.; Ruff C.T.; Sabatine M.S.; The effect of PCSK9 (proprotein convertase subtilisin\/kexin type 9) inhibition on the risk of venous thromboembolism. Circulation  2020,141(20),1600-1607","journal-title":"Circulation"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.21037\/cdt.2017.09.12","volume":"7","author":"Wallace A.","year":"2017","unstructured":"Wallace A.; Albadawi H.; Hoang P.; Fleck A.; Naidu S.; Knuttinen G.; Oklu R.; Statins as a preventative therapy for venous thromboembolism. Cardiovasc Diagn Ther  2017,7(S3),S207-S218","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1161\/CIRCRESAHA.108.182220","volume":"103","author":"Arslan F.","year":"2008","unstructured":"Arslan F.; Pasterkamp G.; de Kleijn D.P.; Unraveling pleiotropic effects of statins: Bit by bit, a slow case with perspective. Circ Res  2008,103(4),334-336","journal-title":"Circ Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.104.525774","volume":"112","author":"Sen-Banerjee S.","year":"2005","unstructured":"Sen-Banerjee S.; Mir S.; Lin Z.; Hamik A.; Atkins G.B.; Das H.; Banerjee P.; Kumar A.; Jain M.K.; Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation  2005,112(5),720-726","journal-title":"Circulation"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S2352-3026(16)30184-3","volume":"4","author":"Kunutsor S.K.","year":"2017","unstructured":"Kunutsor S.K.; Seidu S.; Khunti K.; Statins and primary prevention of venous thromboembolism: A systematic review and meta-analysis. Lancet Haematol  2017,4(2),e83-e93","journal-title":"Lancet Haematol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e2112820","DOI":"10.1001\/jamanetworkopen.2021.12820","volume":"4","author":"Liu G.","year":"2021","unstructured":"Liu G.; Shi M.; Mosley J.D.; Weng C.; Zhang Y.; Lee M.T.M.; Jarvik G.P.; Hakonarson H.; Khales N.B.; Sleiman P.; Luo Y.; Mentch F.; Denny J.C.; Linton M.F.; Wei W.Q.; Stein C.M.; Feng Q.; A mendelian randomization approach using 3-HMG-Coenzyme-A reductase gene variation to evaluate the association of statin-induced low-density lipoprotein cholesterol lowering with noncardiovascular disease phenotypes. JAMA Netw Open  2021,4(6),e2112820","journal-title":"JAMA Netw Open"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.numecd.2023.02.023","volume":"33","author":"Ma X.S.","year":"2023","unstructured":"Ma X.S.; Sun J.; Geng R.; Zhao Y.; Xu W.Z.; Liu Y.H.; Jiang Y.N.; Li Y.Q.; Statins and risk of venous thromboembolic diseases: A two-sample mendelian randomization study. Nutr Metab Cardiovasc Dis  2023,33(5),1087-1092","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"CD008203","DOI":"10.1002\/14651858.CD008203.pub3","author":"Li L.","year":"2014","unstructured":"Li L.; Zhang P.; Tian J.H.; Yang K.; Statins for primary prevention of venous thromboembolism. Cochrane Libr  2014(12),CD008203","journal-title":"Cochrane Libr"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/EJA.0000000000000705","volume":"35","author":"Langenecker K.S.","year":"2018","unstructured":"Langenecker K.S.; Eriksen F.C.; Thienpont E.; Barauskas G.; European guidelines on perioperative venous thromboembolism prophylaxis. Eur J Anaesthesiol  2018,35(2),116-122","journal-title":"Eur J Anaesthesiol"},{"key":"ref=40","doi-asserted-by":"publisher","DOI":"10.2174\/0115701611267835231210054909","volume":"22","author":"Mukherjee D.","year":"2023","unstructured":"Mukherjee D.; Nissen S.E.; Lipoprotein (a) as a biomarker for cardiovascular diseases and potential new therapies to mitigate risk. Curr Vasc Pharmacol  2023,22","journal-title":"Curr Vasc Pharmacol"}],"container-title":["Current Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701611308323240229050237","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/227600\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701611308323240229050237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T11:17:01Z","timestamp":1727695021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/227600\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115701611308323240229050237","relation":{},"ISSN":["1570-1611"],"issn-type":[{"type":"print","value":"1570-1611"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-02-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}